Dosing initiates in phase I study of GFB-024 in severe insulin-resistant diabetic nephropathy May 14, 2021 No Comments
Nephraegis Therapeutics to develop NPH-022 for the prevention and treatment of AKI May 13, 2021 No Comments
Phase III FIGARO-DKD cardiovascular outcomes study of finerenone meets primary endpoint May 10, 2021 No Comments
Pooled data from the AURORA and AURA-LV trials across lupus nephritis biopsy classes April 12, 2021 No Comments
RSS